tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY

Santen Pharmaceutical Co (SNPHY) Revenue

Compare
6 Followers

Santen Pharmaceutical Co Revenue

Santen Pharmaceutical Co had a revenue of 468.85M in the quarter ending Sep 30, 2025, with -99.32%. This bring the company's revenue in the last twelve months to 222.81B, Increased -24.21%. In the fiscal year ending Dec 31, 2025, Santen Pharmaceutical Co had annual revenue of 300.00B with -0.65% growth.
Revenue (ttm)
222.81B
Revenue Growth
-3.03%
P/S Ratio
0.01
Revenue/Employee
$80,129,274
Employees
3,744
Market Cap
$3.35B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
300.00B-1.96B+99.35%
Dec 31, 2024
301.96B22.93B+108.22%
Dec 31, 2023
279.04B12.78B+104.80%
Dec 31, 2022
266.26B16.65B+106.67%
Dec 31, 2021
249.60B8.05B+103.33%
Dec 31, 2020
241.56B7.53B+103.22%
Dec 31, 2019
234.03B9.08B+104.04%
Dec 31, 2018
224.94B25.85B+112.98%
Dec 31, 2017
199.10B3.81B+101.95%
Dec 31, 2016
195.29B